A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

Completed · Phase 3

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to determine the efficacy and safety of relugolix 120 milligrams (mg) orally once daily for 48 weeks on maintaining serum testosterone suppression to castrate levels (\< 50 nanograms/deciliter \[ng/dL\]) in participants with androgen-sensitive advanced prostate cancer.

Key facts

Study ID

NCT03085095

Run by

Myovant Sciences GmbH

People needed

1134

Starts

2017-04-18

Expected to finish

2021-11-26

Last updated by the study team

2022-01-18

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Orange — Orange, California, United States
• Denver — Denver, Colorado, United States
• Pompano Beach — Pompano Beach, Florida, United States
• Jeffersonville — Jeffersonville, Indiana, United States
• Des Moines — Des Moines, Iowa, United States
• Wichita — Wichita, Kansas, United States
• Baltimore — Baltimore, Maryland, United States
• Troy — Troy, Michigan, United States
• Omaha — Omaha, Nebraska, United States
• Las Vegas — Las Vegas, Nevada, United States
• Brick — Brick, New Jersey, United States
• Albuquerque — Albuquerque, New Mexico, United States
• Albany — Albany, New York, United States
• Garden City — Garden City, New York, United States
• Plainview — Plainview, New York, United States
• Poughkeepsie — Poughkeepsie, New York, United States
• Syracuse — Syracuse, New York, United States
• Durham — Durham, North Carolina, United States
• Greensboro — Greensboro, North Carolina, United States
• Cincinnati — Cincinnati, Ohio, United States
• Middleburg Heights — Middleburg Heights, Ohio, United States
• Oklahoma City — Oklahoma City, Oklahoma, United States
• Lancaster — Lancaster, Pennsylvania, United States
• Myrtle Beach — Myrtle Beach, South Carolina, United States
• Tucson — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.